Nicotine’s new appeal

Mimicking the addictive compound’s action in the brain could lead to new drugs for Alzheimer’s, Parkinson’s and schizophrenia

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Chemistry

From the Nature Index

Paid Content